nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Gemcitabine—kidney cancer	0.321	1	CrCtD
Lamivudine—PGK1—kidney cancer	0.201	0.955	CbGaD
Lamivudine—Zalcitabine—Gemcitabine—kidney cancer	0.087	0.522	CrCrCtD
Lamivudine—CMPK1—Gemcitabine—kidney cancer	0.0663	0.338	CbGbCtD
Lamivudine—Cytarabine—Gemcitabine—kidney cancer	0.0418	0.251	CrCrCtD
Lamivudine—Decitabine—Gemcitabine—kidney cancer	0.0378	0.227	CrCrCtD
Lamivudine—DCK—Gemcitabine—kidney cancer	0.017	0.0863	CbGbCtD
Lamivudine—ABCB1—kidney cancer	0.00953	0.0453	CbGaD
Lamivudine—ABCC3—Vincristine—kidney cancer	0.00685	0.0349	CbGbCtD
Lamivudine—ABCC1—Dactinomycin—kidney cancer	0.00683	0.0348	CbGbCtD
Lamivudine—SLC22A3—Vincristine—kidney cancer	0.00644	0.0328	CbGbCtD
Lamivudine—ABCC4—Sorafenib—kidney cancer	0.00539	0.0274	CbGbCtD
Lamivudine—ABCG2—Pazopanib—kidney cancer	0.005	0.0254	CbGbCtD
Lamivudine—ABCC1—Paclitaxel—kidney cancer	0.00488	0.0248	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—kidney cancer	0.00457	0.0233	CbGbCtD
Lamivudine—ABCC4—Sunitinib—kidney cancer	0.00437	0.0222	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—kidney cancer	0.00428	0.0218	CbGbCtD
Lamivudine—ABCC1—Vinblastine—kidney cancer	0.00428	0.0218	CbGbCtD
Lamivudine—ABCC1—Vincristine—kidney cancer	0.00421	0.0214	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—kidney cancer	0.00388	0.0197	CbGbCtD
Lamivudine—ABCC2—Paclitaxel—kidney cancer	0.00361	0.0184	CbGbCtD
Lamivudine—ABCG2—Erlotinib—kidney cancer	0.00357	0.0182	CbGbCtD
Lamivudine—ABCB1—Temsirolimus—kidney cancer	0.00343	0.0175	CbGbCtD
Lamivudine—ABCG2—Paclitaxel—kidney cancer	0.00326	0.0166	CbGbCtD
Lamivudine—ABCC2—Sorafenib—kidney cancer	0.00321	0.0163	CbGbCtD
Lamivudine—ABCC2—Vinblastine—kidney cancer	0.00317	0.0161	CbGbCtD
Lamivudine—ABCC2—Vincristine—kidney cancer	0.00311	0.0158	CbGbCtD
Lamivudine—ABCG2—Sorafenib—kidney cancer	0.0029	0.0148	CbGbCtD
Lamivudine—ABCG2—Vincristine—kidney cancer	0.00282	0.0143	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—kidney cancer	0.00263	0.0134	CbGbCtD
Lamivudine—ABCC2—Sunitinib—kidney cancer	0.0026	0.0132	CbGbCtD
Lamivudine—ABCG2—Sunitinib—kidney cancer	0.00235	0.012	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—kidney cancer	0.00195	0.00991	CbGbCtD
Lamivudine—ABCB1—Pazopanib—kidney cancer	0.0018	0.00917	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—kidney cancer	0.00176	0.00896	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—kidney cancer	0.00165	0.00839	CbGbCtD
Lamivudine—SLC22A2—nephron—kidney cancer	0.00146	0.0805	CbGeAlD
Lamivudine—ABCB1—Gemcitabine—kidney cancer	0.0013	0.00663	CbGbCtD
Lamivudine—ABCB1—Erlotinib—kidney cancer	0.00129	0.00655	CbGbCtD
Lamivudine—ABCB1—Paclitaxel—kidney cancer	0.00118	0.00599	CbGbCtD
Lamivudine—PCYT2—renal system—kidney cancer	0.00108	0.0599	CbGeAlD
Lamivudine—PCYT2—kidney—kidney cancer	0.00105	0.0579	CbGeAlD
Lamivudine—ABCB1—Sorafenib—kidney cancer	0.00105	0.00532	CbGbCtD
Lamivudine—ABCB1—Vinblastine—kidney cancer	0.00103	0.00526	CbGbCtD
Lamivudine—ABCB1—Vincristine—kidney cancer	0.00102	0.00517	CbGbCtD
Lamivudine—PCYT2—gonad—kidney cancer	0.000972	0.0537	CbGeAlD
Lamivudine—ABCB1—Sunitinib—kidney cancer	0.000847	0.00431	CbGbCtD
Lamivudine—PGK1—gonad—kidney cancer	0.000835	0.0462	CbGeAlD
Lamivudine—NT5C—renal system—kidney cancer	0.000786	0.0435	CbGeAlD
Lamivudine—PCYT1A—renal system—kidney cancer	0.000738	0.0408	CbGeAlD
Lamivudine—PCYT1A—gonad—kidney cancer	0.000662	0.0366	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—kidney cancer	0.000634	0.00323	CbGbCtD
Lamivudine—CMPK1—nephron tubule—kidney cancer	0.000523	0.0289	CbGeAlD
Lamivudine—NME1—renal system—kidney cancer	0.000493	0.0273	CbGeAlD
Lamivudine—NME1—kidney—kidney cancer	0.000477	0.0264	CbGeAlD
Lamivudine—CMPK1—renal system—kidney cancer	0.000475	0.0263	CbGeAlD
Lamivudine—NME2—renal system—kidney cancer	0.000465	0.0257	CbGeAlD
Lamivudine—CMPK1—kidney—kidney cancer	0.00046	0.0254	CbGeAlD
Lamivudine—CMPK1—cortex of kidney—kidney cancer	0.000448	0.0247	CbGeAlD
Lamivudine—CMPK1—gonad—kidney cancer	0.000426	0.0236	CbGeAlD
Lamivudine—CMPK1—cardiac atrium—kidney cancer	0.000426	0.0235	CbGeAlD
Lamivudine—SLC22A6—nephron tubule—kidney cancer	0.000341	0.0189	CbGeAlD
Lamivudine—SLC22A2—nephron tubule—kidney cancer	0.000314	0.0174	CbGeAlD
Lamivudine—SLC22A6—cortex of kidney—kidney cancer	0.000292	0.0161	CbGeAlD
Lamivudine—SLC22A2—renal system—kidney cancer	0.000286	0.0158	CbGeAlD
Lamivudine—SLC22A2—kidney—kidney cancer	0.000276	0.0153	CbGeAlD
Lamivudine—SLC22A2—cortex of kidney—kidney cancer	0.000269	0.0149	CbGeAlD
Lamivudine—DCK—nephron tubule—kidney cancer	0.00026	0.0144	CbGeAlD
Lamivudine—ABCC3—renal system—kidney cancer	0.000227	0.0125	CbGeAlD
Lamivudine—DCK—cortex of kidney—kidney cancer	0.000223	0.0123	CbGeAlD
Lamivudine—ABCC3—kidney—kidney cancer	0.000219	0.0121	CbGeAlD
Lamivudine—DCK—gonad—kidney cancer	0.000212	0.0117	CbGeAlD
Lamivudine—DCK—cardiac atrium—kidney cancer	0.000212	0.0117	CbGeAlD
Lamivudine—ABCC4—nephron tubule—kidney cancer	0.000206	0.0114	CbGeAlD
Lamivudine—SLC22A1—renal system—kidney cancer	0.000202	0.0112	CbGeAlD
Lamivudine—ABCC2—nephron tubule—kidney cancer	0.000199	0.011	CbGeAlD
Lamivudine—SLC22A1—kidney—kidney cancer	0.000195	0.0108	CbGeAlD
Lamivudine—SLC22A3—renal system—kidney cancer	0.000193	0.0107	CbGeAlD
Lamivudine—ABCC4—renal system—kidney cancer	0.000187	0.0103	CbGeAlD
Lamivudine—SLC22A3—kidney—kidney cancer	0.000187	0.0103	CbGeAlD
Lamivudine—ABCC2—renal system—kidney cancer	0.000181	0.01	CbGeAlD
Lamivudine—ABCC4—kidney—kidney cancer	0.000181	0.01	CbGeAlD
Lamivudine—ABCC4—cortex of kidney—kidney cancer	0.000176	0.00974	CbGeAlD
Lamivudine—ABCC2—kidney—kidney cancer	0.000175	0.00968	CbGeAlD
Lamivudine—SLC22A3—gonad—kidney cancer	0.000173	0.00957	CbGeAlD
Lamivudine—ABCC2—cortex of kidney—kidney cancer	0.00017	0.00943	CbGeAlD
Lamivudine—NME1—Temsirolimus—Everolimus—kidney cancer	0.00016	0.152	CbGdCrCtD
Lamivudine—NME1—Sirolimus—Everolimus—kidney cancer	0.00016	0.152	CbGdCrCtD
Lamivudine—NME1—Everolimus—Temsirolimus—kidney cancer	0.00016	0.152	CbGdCrCtD
Lamivudine—NME1—Sirolimus—Temsirolimus—kidney cancer	0.00016	0.152	CbGdCrCtD
Lamivudine—NME1—Gefitinib—Erlotinib—kidney cancer	0.00016	0.152	CbGdCrCtD
Lamivudine—ABCC1—cortex of kidney—kidney cancer	0.00015	0.0083	CbGeAlD
Lamivudine—ABCG2—nephron tubule—kidney cancer	0.000145	0.00803	CbGeAlD
Lamivudine—ABCC1—cardiac atrium—kidney cancer	0.000143	0.0079	CbGeAlD
Lamivudine—DCK—Sirolimus—Everolimus—kidney cancer	0.000109	0.103	CbGdCrCtD
Lamivudine—DCK—Sirolimus—Temsirolimus—kidney cancer	0.000109	0.103	CbGdCrCtD
Lamivudine—ABCB1—nephron tubule—kidney cancer	7.16e-05	0.00396	CbGeAlD
Lamivudine—ABCB1—renal system—kidney cancer	6.51e-05	0.0036	CbGeAlD
Lamivudine—ABCB1—kidney—kidney cancer	6.29e-05	0.00348	CbGeAlD
Lamivudine—ABCB1—cortex of kidney—kidney cancer	6.13e-05	0.00339	CbGeAlD
Lamivudine—ABCB1—gonad—kidney cancer	5.84e-05	0.00323	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—kidney cancer	3.51e-05	0.0333	CbGdCrCtD
Lamivudine—Chest pain—Paclitaxel—kidney cancer	2.08e-05	0.00039	CcSEcCtD
Lamivudine—Myalgia—Paclitaxel—kidney cancer	2.08e-05	0.00039	CcSEcCtD
Lamivudine—Arthralgia—Paclitaxel—kidney cancer	2.08e-05	0.00039	CcSEcCtD
Lamivudine—Mediastinal disorder—Capecitabine—kidney cancer	2.07e-05	0.000389	CcSEcCtD
Lamivudine—Anxiety—Paclitaxel—kidney cancer	2.07e-05	0.000389	CcSEcCtD
Lamivudine—Decreased appetite—Gemcitabine—kidney cancer	2.07e-05	0.000388	CcSEcCtD
Lamivudine—Hypersensitivity—Dactinomycin—kidney cancer	2.07e-05	0.000388	CcSEcCtD
Lamivudine—Chills—Capecitabine—kidney cancer	2.06e-05	0.000388	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.06e-05	0.000387	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.05e-05	0.000386	CcSEcCtD
Lamivudine—Discomfort—Paclitaxel—kidney cancer	2.05e-05	0.000385	CcSEcCtD
Lamivudine—Fatigue—Gemcitabine—kidney cancer	2.05e-05	0.000385	CcSEcCtD
Lamivudine—Gastrointestinal pain—Vincristine—kidney cancer	2.05e-05	0.000385	CcSEcCtD
Lamivudine—Dizziness—Sorafenib—kidney cancer	2.04e-05	0.000383	CcSEcCtD
Lamivudine—Pain—Gemcitabine—kidney cancer	2.03e-05	0.000382	CcSEcCtD
Lamivudine—Constipation—Gemcitabine—kidney cancer	2.03e-05	0.000382	CcSEcCtD
Lamivudine—Nausea—Erlotinib—kidney cancer	2.03e-05	0.000382	CcSEcCtD
Lamivudine—Alopecia—Capecitabine—kidney cancer	2.03e-05	0.000382	CcSEcCtD
Lamivudine—Dry mouth—Paclitaxel—kidney cancer	2.03e-05	0.000382	CcSEcCtD
Lamivudine—Mood swings—Doxorubicin—kidney cancer	2.03e-05	0.000381	CcSEcCtD
Lamivudine—Diarrhoea—Sunitinib—kidney cancer	2.03e-05	0.000381	CcSEcCtD
Lamivudine—Asthenia—Dactinomycin—kidney cancer	2.01e-05	0.000378	CcSEcCtD
Lamivudine—Confusional state—Paclitaxel—kidney cancer	2.01e-05	0.000377	CcSEcCtD
Lamivudine—Malnutrition—Capecitabine—kidney cancer	2e-05	0.000376	CcSEcCtD
Lamivudine—Erythema—Capecitabine—kidney cancer	2e-05	0.000376	CcSEcCtD
Lamivudine—Dehydration—Doxorubicin—kidney cancer	1.99e-05	0.000374	CcSEcCtD
Lamivudine—Oedema—Paclitaxel—kidney cancer	1.99e-05	0.000374	CcSEcCtD
Lamivudine—Anaphylactic shock—Paclitaxel—kidney cancer	1.99e-05	0.000374	CcSEcCtD
Lamivudine—Body temperature increased—Vincristine—kidney cancer	1.98e-05	0.000372	CcSEcCtD
Lamivudine—Abdominal pain—Vincristine—kidney cancer	1.98e-05	0.000372	CcSEcCtD
Lamivudine—Liver function test abnormal—Doxorubicin—kidney cancer	1.98e-05	0.000372	CcSEcCtD
Lamivudine—Infection—Paclitaxel—kidney cancer	1.98e-05	0.000372	CcSEcCtD
Lamivudine—Flatulence—Capecitabine—kidney cancer	1.97e-05	0.000371	CcSEcCtD
Lamivudine—Dysgeusia—Capecitabine—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Dizziness—Sunitinib—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Feeling abnormal—Gemcitabine—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Shock—Paclitaxel—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Vomiting—Sorafenib—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Abdominal pain upper—Doxorubicin—kidney cancer	1.96e-05	0.000368	CcSEcCtD
Lamivudine—Nervous system disorder—Paclitaxel—kidney cancer	1.95e-05	0.000367	CcSEcCtD
Lamivudine—Thrombocytopenia—Paclitaxel—kidney cancer	1.95e-05	0.000366	CcSEcCtD
Lamivudine—Rash—Sorafenib—kidney cancer	1.94e-05	0.000365	CcSEcCtD
Lamivudine—Dermatitis—Sorafenib—kidney cancer	1.94e-05	0.000364	CcSEcCtD
Lamivudine—Back pain—Capecitabine—kidney cancer	1.93e-05	0.000364	CcSEcCtD
Lamivudine—Skin disorder—Paclitaxel—kidney cancer	1.93e-05	0.000363	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.93e-05	0.000362	CcSEcCtD
Lamivudine—Headache—Sorafenib—kidney cancer	1.93e-05	0.000362	CcSEcCtD
Lamivudine—Muscle spasms—Capecitabine—kidney cancer	1.92e-05	0.000362	CcSEcCtD
Lamivudine—Hyperhidrosis—Paclitaxel—kidney cancer	1.92e-05	0.000362	CcSEcCtD
Lamivudine—Diarrhoea—Dactinomycin—kidney cancer	1.92e-05	0.000361	CcSEcCtD
Lamivudine—Nasopharyngitis—Doxorubicin—kidney cancer	1.91e-05	0.00036	CcSEcCtD
Lamivudine—Anorexia—Paclitaxel—kidney cancer	1.9e-05	0.000357	CcSEcCtD
Lamivudine—Muscular weakness—Doxorubicin—kidney cancer	1.89e-05	0.000355	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	1.89e-05	0.000355	CcSEcCtD
Lamivudine—Vomiting—Sunitinib—kidney cancer	1.88e-05	0.000354	CcSEcCtD
Lamivudine—Body temperature increased—Gemcitabine—kidney cancer	1.88e-05	0.000353	CcSEcCtD
Lamivudine—Tremor—Capecitabine—kidney cancer	1.87e-05	0.000352	CcSEcCtD
Lamivudine—Rash—Sunitinib—kidney cancer	1.87e-05	0.000351	CcSEcCtD
Lamivudine—Dermatitis—Sunitinib—kidney cancer	1.87e-05	0.000351	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—kidney cancer	1.86e-05	0.00035	CcSEcCtD
Lamivudine—Hypotension—Paclitaxel—kidney cancer	1.86e-05	0.000349	CcSEcCtD
Lamivudine—Ill-defined disorder—Capecitabine—kidney cancer	1.86e-05	0.000349	CcSEcCtD
Lamivudine—Headache—Sunitinib—kidney cancer	1.86e-05	0.000349	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—kidney cancer	1.85e-05	0.000348	CcSEcCtD
Lamivudine—Influenza—Doxorubicin—kidney cancer	1.85e-05	0.000348	CcSEcCtD
Lamivudine—Anaemia—Capecitabine—kidney cancer	1.85e-05	0.000348	CcSEcCtD
Lamivudine—Hypersensitivity—Vincristine—kidney cancer	1.85e-05	0.000347	CcSEcCtD
Lamivudine—Nausea—Sorafenib—kidney cancer	1.83e-05	0.000344	CcSEcCtD
Lamivudine—Pancreatitis—Doxorubicin—kidney cancer	1.81e-05	0.000341	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.81e-05	0.000341	CcSEcCtD
Lamivudine—Malaise—Capecitabine—kidney cancer	1.8e-05	0.000339	CcSEcCtD
Lamivudine—Insomnia—Paclitaxel—kidney cancer	1.8e-05	0.000338	CcSEcCtD
Lamivudine—Vertigo—Capecitabine—kidney cancer	1.8e-05	0.000338	CcSEcCtD
Lamivudine—Asthenia—Vincristine—kidney cancer	1.8e-05	0.000338	CcSEcCtD
Lamivudine—Syncope—Capecitabine—kidney cancer	1.79e-05	0.000337	CcSEcCtD
Lamivudine—Leukopenia—Capecitabine—kidney cancer	1.79e-05	0.000337	CcSEcCtD
Lamivudine—Paraesthesia—Paclitaxel—kidney cancer	1.79e-05	0.000336	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—kidney cancer	1.78e-05	0.000335	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—kidney cancer	1.78e-05	0.000335	CcSEcCtD
Lamivudine—Dyspnoea—Paclitaxel—kidney cancer	1.77e-05	0.000333	CcSEcCtD
Lamivudine—Somnolence—Paclitaxel—kidney cancer	1.77e-05	0.000333	CcSEcCtD
Lamivudine—Rash—Dactinomycin—kidney cancer	1.77e-05	0.000332	CcSEcCtD
Lamivudine—Nausea—Sunitinib—kidney cancer	1.76e-05	0.000331	CcSEcCtD
Lamivudine—Loss of consciousness—Capecitabine—kidney cancer	1.76e-05	0.000331	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—kidney cancer	1.76e-05	0.00033	CcSEcCtD
Lamivudine—Dyspepsia—Paclitaxel—kidney cancer	1.75e-05	0.000329	CcSEcCtD
Lamivudine—Cough—Capecitabine—kidney cancer	1.75e-05	0.000328	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—kidney cancer	1.73e-05	0.000325	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—kidney cancer	1.73e-05	0.000325	CcSEcCtD
Lamivudine—Decreased appetite—Paclitaxel—kidney cancer	1.73e-05	0.000325	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.72e-05	0.000323	CcSEcCtD
Lamivudine—Fatigue—Paclitaxel—kidney cancer	1.72e-05	0.000322	CcSEcCtD
Lamivudine—Diarrhoea—Vincristine—kidney cancer	1.71e-05	0.000322	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—kidney cancer	1.71e-05	0.000321	CcSEcCtD
Lamivudine—Asthenia—Gemcitabine—kidney cancer	1.7e-05	0.000321	CcSEcCtD
Lamivudine—Arthralgia—Capecitabine—kidney cancer	1.7e-05	0.00032	CcSEcCtD
Lamivudine—Myalgia—Capecitabine—kidney cancer	1.7e-05	0.00032	CcSEcCtD
Lamivudine—Chest pain—Capecitabine—kidney cancer	1.7e-05	0.00032	CcSEcCtD
Lamivudine—Pain—Paclitaxel—kidney cancer	1.7e-05	0.00032	CcSEcCtD
Lamivudine—Constipation—Paclitaxel—kidney cancer	1.7e-05	0.00032	CcSEcCtD
Lamivudine—Anxiety—Capecitabine—kidney cancer	1.7e-05	0.000319	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.69e-05	0.000318	CcSEcCtD
Lamivudine—Discomfort—Capecitabine—kidney cancer	1.68e-05	0.000316	CcSEcCtD
Lamivudine—Pruritus—Gemcitabine—kidney cancer	1.68e-05	0.000316	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—kidney cancer	1.67e-05	0.000314	CcSEcCtD
Lamivudine—Dry mouth—Capecitabine—kidney cancer	1.67e-05	0.000313	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—kidney cancer	1.67e-05	0.000313	CcSEcCtD
Lamivudine—Dizziness—Vincristine—kidney cancer	1.66e-05	0.000311	CcSEcCtD
Lamivudine—Confusional state—Capecitabine—kidney cancer	1.65e-05	0.000309	CcSEcCtD
Lamivudine—Feeling abnormal—Paclitaxel—kidney cancer	1.64e-05	0.000308	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.64e-05	0.000308	CcSEcCtD
Lamivudine—Oedema—Capecitabine—kidney cancer	1.63e-05	0.000307	CcSEcCtD
Lamivudine—Gastrointestinal pain—Paclitaxel—kidney cancer	1.63e-05	0.000306	CcSEcCtD
Lamivudine—Diarrhoea—Gemcitabine—kidney cancer	1.63e-05	0.000306	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—kidney cancer	1.62e-05	0.000305	CcSEcCtD
Lamivudine—Infection—Capecitabine—kidney cancer	1.62e-05	0.000305	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.62e-05	0.000304	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—kidney cancer	1.61e-05	0.000302	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—kidney cancer	1.61e-05	0.000302	CcSEcCtD
Lamivudine—Shock—Capecitabine—kidney cancer	1.61e-05	0.000302	CcSEcCtD
Lamivudine—Nervous system disorder—Capecitabine—kidney cancer	1.6e-05	0.000301	CcSEcCtD
Lamivudine—Thrombocytopenia—Capecitabine—kidney cancer	1.6e-05	0.000301	CcSEcCtD
Lamivudine—Vomiting—Vincristine—kidney cancer	1.59e-05	0.000299	CcSEcCtD
Lamivudine—Skin disorder—Capecitabine—kidney cancer	1.59e-05	0.000298	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—kidney cancer	1.58e-05	0.000297	CcSEcCtD
Lamivudine—Urticaria—Paclitaxel—kidney cancer	1.58e-05	0.000297	CcSEcCtD
Lamivudine—Rash—Vincristine—kidney cancer	1.58e-05	0.000297	CcSEcCtD
Lamivudine—Hyperhidrosis—Capecitabine—kidney cancer	1.58e-05	0.000297	CcSEcCtD
Lamivudine—Dermatitis—Vincristine—kidney cancer	1.58e-05	0.000297	CcSEcCtD
Lamivudine—Abdominal pain—Paclitaxel—kidney cancer	1.57e-05	0.000296	CcSEcCtD
Lamivudine—Body temperature increased—Paclitaxel—kidney cancer	1.57e-05	0.000296	CcSEcCtD
Lamivudine—Headache—Vincristine—kidney cancer	1.57e-05	0.000295	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—kidney cancer	1.56e-05	0.000293	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—kidney cancer	1.56e-05	0.000293	CcSEcCtD
Lamivudine—Anorexia—Capecitabine—kidney cancer	1.56e-05	0.000293	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—kidney cancer	1.55e-05	0.000291	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—kidney cancer	1.54e-05	0.000289	CcSEcCtD
Lamivudine—Hypotension—Capecitabine—kidney cancer	1.53e-05	0.000287	CcSEcCtD
Lamivudine—Vomiting—Gemcitabine—kidney cancer	1.51e-05	0.000284	CcSEcCtD
Lamivudine—Rash—Gemcitabine—kidney cancer	1.5e-05	0.000282	CcSEcCtD
Lamivudine—Dermatitis—Gemcitabine—kidney cancer	1.5e-05	0.000281	CcSEcCtD
Lamivudine—Headache—Gemcitabine—kidney cancer	1.49e-05	0.00028	CcSEcCtD
Lamivudine—Nausea—Vincristine—kidney cancer	1.49e-05	0.00028	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.49e-05	0.00028	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—kidney cancer	1.49e-05	0.000279	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—kidney cancer	1.48e-05	0.000278	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—kidney cancer	1.48e-05	0.000278	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—kidney cancer	1.47e-05	0.000277	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—kidney cancer	1.47e-05	0.000276	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—kidney cancer	1.47e-05	0.000276	CcSEcCtD
Lamivudine—Hypersensitivity—Paclitaxel—kidney cancer	1.47e-05	0.000276	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—kidney cancer	1.46e-05	0.000274	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—kidney cancer	1.46e-05	0.000274	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—kidney cancer	1.44e-05	0.00027	CcSEcCtD
Lamivudine—Asthenia—Paclitaxel—kidney cancer	1.43e-05	0.000268	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—kidney cancer	1.42e-05	0.000267	CcSEcCtD
Lamivudine—Nausea—Gemcitabine—kidney cancer	1.41e-05	0.000265	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—kidney cancer	1.41e-05	0.000265	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—kidney cancer	1.41e-05	0.000265	CcSEcCtD
Lamivudine—Pruritus—Paclitaxel—kidney cancer	1.41e-05	0.000265	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—kidney cancer	1.4e-05	0.000263	CcSEcCtD
Lamivudine—Pain—Capecitabine—kidney cancer	1.4e-05	0.000262	CcSEcCtD
Lamivudine—Constipation—Capecitabine—kidney cancer	1.4e-05	0.000262	CcSEcCtD
Lamivudine—Diarrhoea—Paclitaxel—kidney cancer	1.36e-05	0.000256	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—kidney cancer	1.35e-05	0.000253	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—kidney cancer	1.34e-05	0.000252	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—kidney cancer	1.34e-05	0.000251	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—kidney cancer	1.33e-05	0.000251	CcSEcCtD
Lamivudine—Chills—Doxorubicin—kidney cancer	1.33e-05	0.00025	CcSEcCtD
Lamivudine—Dizziness—Paclitaxel—kidney cancer	1.32e-05	0.000247	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—kidney cancer	1.31e-05	0.000246	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—kidney cancer	1.3e-05	0.000244	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—kidney cancer	1.29e-05	0.000243	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—kidney cancer	1.29e-05	0.000243	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—kidney cancer	1.29e-05	0.000242	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—kidney cancer	1.29e-05	0.000242	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—kidney cancer	1.27e-05	0.000239	CcSEcCtD
Lamivudine—Tension—Doxorubicin—kidney cancer	1.27e-05	0.000238	CcSEcCtD
Lamivudine—Vomiting—Paclitaxel—kidney cancer	1.26e-05	0.000238	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—kidney cancer	1.26e-05	0.000237	CcSEcCtD
Lamivudine—Rash—Paclitaxel—kidney cancer	1.25e-05	0.000236	CcSEcCtD
Lamivudine—Dermatitis—Paclitaxel—kidney cancer	1.25e-05	0.000236	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—kidney cancer	1.25e-05	0.000235	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—kidney cancer	1.25e-05	0.000234	CcSEcCtD
Lamivudine—Headache—Paclitaxel—kidney cancer	1.25e-05	0.000234	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—kidney cancer	1.24e-05	0.000233	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—kidney cancer	1.2e-05	0.000226	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—kidney cancer	1.2e-05	0.000225	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—kidney cancer	1.19e-05	0.000224	CcSEcCtD
Lamivudine—Nausea—Paclitaxel—kidney cancer	1.18e-05	0.000222	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—kidney cancer	1.17e-05	0.00022	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—kidney cancer	1.16e-05	0.000219	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—kidney cancer	1.16e-05	0.000218	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—kidney cancer	1.16e-05	0.000217	CcSEcCtD
Lamivudine—Pruritus—Capecitabine—kidney cancer	1.16e-05	0.000217	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—kidney cancer	1.15e-05	0.000217	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—kidney cancer	1.13e-05	0.000213	CcSEcCtD
Lamivudine—Cough—Doxorubicin—kidney cancer	1.13e-05	0.000212	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—kidney cancer	1.12e-05	0.00021	CcSEcCtD
Lamivudine—Diarrhoea—Capecitabine—kidney cancer	1.12e-05	0.00021	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—kidney cancer	1.1e-05	0.000206	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—kidney cancer	1.1e-05	0.000206	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—kidney cancer	1.1e-05	0.000206	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—kidney cancer	1.09e-05	0.000206	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.09e-05	0.000205	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—kidney cancer	1.08e-05	0.000204	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—kidney cancer	1.08e-05	0.000203	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—kidney cancer	1.07e-05	0.000202	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—kidney cancer	1.06e-05	0.000199	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—kidney cancer	1.05e-05	0.000198	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—kidney cancer	1.05e-05	0.000198	CcSEcCtD
Lamivudine—Infection—Doxorubicin—kidney cancer	1.05e-05	0.000197	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—kidney cancer	1.04e-05	0.000195	CcSEcCtD
Lamivudine—Shock—Doxorubicin—kidney cancer	1.04e-05	0.000195	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—kidney cancer	1.03e-05	0.000194	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—kidney cancer	1.03e-05	0.000194	CcSEcCtD
Lamivudine—Rash—Capecitabine—kidney cancer	1.03e-05	0.000194	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—kidney cancer	1.03e-05	0.000193	CcSEcCtD
Lamivudine—Headache—Capecitabine—kidney cancer	1.02e-05	0.000192	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—kidney cancer	1.02e-05	0.000192	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—kidney cancer	1.02e-05	0.000191	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—kidney cancer	1e-05	0.000189	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—kidney cancer	9.83e-06	0.000185	CcSEcCtD
Lamivudine—Nausea—Capecitabine—kidney cancer	9.7e-06	0.000182	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.59e-06	0.00018	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—kidney cancer	9.52e-06	0.000179	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—kidney cancer	9.45e-06	0.000178	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—kidney cancer	9.38e-06	0.000176	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—kidney cancer	9.36e-06	0.000176	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—kidney cancer	9.26e-06	0.000174	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—kidney cancer	9.15e-06	0.000172	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.09e-06	0.000171	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—kidney cancer	9.07e-06	0.000171	CcSEcCtD
Lamivudine—Pain—Doxorubicin—kidney cancer	9e-06	0.000169	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—kidney cancer	9e-06	0.000169	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—kidney cancer	8.67e-06	0.000163	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—kidney cancer	8.61e-06	0.000162	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—kidney cancer	8.36e-06	0.000157	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—kidney cancer	8.32e-06	0.000156	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—kidney cancer	8.32e-06	0.000156	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—kidney cancer	7.75e-06	0.000146	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—kidney cancer	7.55e-06	0.000142	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—kidney cancer	7.45e-06	0.00014	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—kidney cancer	7.2e-06	0.000135	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—kidney cancer	6.96e-06	0.000131	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—kidney cancer	6.69e-06	0.000126	CcSEcCtD
Lamivudine—Rash—Doxorubicin—kidney cancer	6.64e-06	0.000125	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—kidney cancer	6.63e-06	0.000125	CcSEcCtD
Lamivudine—Headache—Doxorubicin—kidney cancer	6.59e-06	0.000124	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—kidney cancer	6.25e-06	0.000118	CcSEcCtD
Lamivudine—ABCG2—Metabolism—SLC5A3—kidney cancer	4.26e-06	0.000128	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—BRAF—kidney cancer	4.25e-06	0.000128	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—kidney cancer	4.24e-06	0.000127	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A3—kidney cancer	4.22e-06	0.000127	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PGK1—kidney cancer	4.22e-06	0.000127	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.21e-06	0.000126	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ST3GAL2—kidney cancer	4.2e-06	0.000126	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LDHB—kidney cancer	4.18e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.16e-06	0.000125	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTM1—kidney cancer	4.16e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ITPR2—kidney cancer	4.16e-06	0.000125	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LDHB—kidney cancer	4.14e-06	0.000124	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTT1—kidney cancer	4.12e-06	0.000124	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ACHE—kidney cancer	4.12e-06	0.000124	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CA9—kidney cancer	4.12e-06	0.000124	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDH1A1—kidney cancer	4.1e-06	0.000123	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.03e-06	0.000121	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—kidney cancer	4e-06	0.00012	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—kidney cancer	4e-06	0.00012	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—kidney cancer	4e-06	0.00012	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP1A1—kidney cancer	3.94e-06	0.000118	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTEN—kidney cancer	3.93e-06	0.000118	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PGK1—kidney cancer	3.93e-06	0.000118	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A3—kidney cancer	3.93e-06	0.000118	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SCARB1—kidney cancer	3.9e-06	0.000117	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—kidney cancer	3.9e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ITPR2—kidney cancer	3.89e-06	0.000117	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS1—kidney cancer	3.86e-06	0.000116	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LDHB—kidney cancer	3.86e-06	0.000116	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.83e-06	0.000115	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—RAF1—kidney cancer	3.81e-06	0.000114	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTT1—kidney cancer	3.79e-06	0.000114	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ACHE—kidney cancer	3.79e-06	0.000114	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PSMD7—kidney cancer	3.79e-06	0.000114	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.77e-06	0.000113	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PDHB—kidney cancer	3.73e-06	0.000112	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.66e-06	0.00011	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CA9—kidney cancer	3.62e-06	0.000109	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.62e-06	0.000109	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.59e-06	0.000108	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BCHE—kidney cancer	3.59e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SCARB1—kidney cancer	3.59e-06	0.000108	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CA9—kidney cancer	3.59e-06	0.000108	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—RAF1—kidney cancer	3.55e-06	0.000107	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS1—kidney cancer	3.55e-06	0.000107	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC5A5—kidney cancer	3.55e-06	0.000106	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CCBL1—kidney cancer	3.51e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CRABP1—kidney cancer	3.5e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PSMD7—kidney cancer	3.48e-06	0.000104	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A1—kidney cancer	3.43e-06	0.000103	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—kidney cancer	3.42e-06	0.000103	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.41e-06	0.000102	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.38e-06	0.000101	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CA9—kidney cancer	3.34e-06	0.0001	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BCHE—kidney cancer	3.3e-06	9.9e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.27e-06	9.8e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—kidney cancer	3.26e-06	9.79e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RAF1—kidney cancer	3.26e-06	9.79e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC5A5—kidney cancer	3.26e-06	9.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PSMD7—kidney cancer	3.26e-06	9.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ITPR2—kidney cancer	3.26e-06	9.77e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.18e-06	9.54e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A1—kidney cancer	3.15e-06	9.45e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CRABP1—kidney cancer	3.08e-06	9.25e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.06e-06	9.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CRABP1—kidney cancer	3.05e-06	9.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPAT—kidney cancer	3.04e-06	9.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GLIPR1—kidney cancer	3.04e-06	9.12e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—kidney cancer	3.03e-06	9.1e-05	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RAF1—kidney cancer	3e-06	9.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3e-06	9.01e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—kidney cancer	2.98e-06	8.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTT1—kidney cancer	2.97e-06	8.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ACHE—kidney cancer	2.97e-06	8.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A1—kidney cancer	2.95e-06	8.84e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—POMC—kidney cancer	2.94e-06	8.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JUNB—kidney cancer	2.92e-06	8.78e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—kidney cancer	2.92e-06	8.77e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ITPR2—kidney cancer	2.86e-06	8.6e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—kidney cancer	2.86e-06	8.57e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CRABP1—kidney cancer	2.84e-06	8.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ITPR2—kidney cancer	2.84e-06	8.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APRT—kidney cancer	2.83e-06	8.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FH—kidney cancer	2.83e-06	8.48e-05	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.82e-06	8.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.82e-06	8.46e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SCARB1—kidney cancer	2.81e-06	8.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.79e-06	8.37e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS1—kidney cancer	2.78e-06	8.35e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—kidney cancer	2.77e-06	8.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSMD7—kidney cancer	2.73e-06	8.19e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.73e-06	8.18e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—kidney cancer	2.7e-06	8.12e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.66e-06	7.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPC3—kidney cancer	2.66e-06	7.97e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ITPR2—kidney cancer	2.64e-06	7.93e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—kidney cancer	2.63e-06	7.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—kidney cancer	2.63e-06	7.88e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAPK1—kidney cancer	2.61e-06	7.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTT1—kidney cancer	2.61e-06	7.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ACHE—kidney cancer	2.61e-06	7.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.6e-06	7.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BCHE—kidney cancer	2.59e-06	7.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA2—kidney cancer	2.59e-06	7.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTT1—kidney cancer	2.59e-06	7.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ACHE—kidney cancer	2.59e-06	7.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.58e-06	7.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC5A5—kidney cancer	2.55e-06	7.67e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALAD—kidney cancer	2.52e-06	7.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.51e-06	7.52e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A1—kidney cancer	2.49e-06	7.47e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—kidney cancer	2.49e-06	7.46e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—kidney cancer	2.49e-06	7.46e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SCARB1—kidney cancer	2.47e-06	7.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A1—kidney cancer	2.47e-06	7.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.46e-06	7.39e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.46e-06	7.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.46e-06	7.38e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.46e-06	7.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS1—kidney cancer	2.45e-06	7.35e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SCARB1—kidney cancer	2.45e-06	7.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.44e-06	7.32e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAPK1—kidney cancer	2.44e-06	7.31e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS1—kidney cancer	2.42e-06	7.27e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—kidney cancer	2.41e-06	7.24e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ACHE—kidney cancer	2.41e-06	7.23e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—kidney cancer	2.41e-06	7.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.4e-06	7.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSMD7—kidney cancer	2.4e-06	7.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.39e-06	7.18e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.38e-06	7.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—kidney cancer	2.38e-06	7.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.38e-06	7.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSMD7—kidney cancer	2.38e-06	7.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.35e-06	7.06e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—kidney cancer	2.35e-06	7.05e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—kidney cancer	2.34e-06	7.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PGK1—kidney cancer	2.3e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A3—kidney cancer	2.3e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—kidney cancer	2.29e-06	6.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SCARB1—kidney cancer	2.28e-06	6.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BCHE—kidney cancer	2.28e-06	6.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LDHB—kidney cancer	2.26e-06	6.78e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS1—kidney cancer	2.26e-06	6.78e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BCHE—kidney cancer	2.25e-06	6.76e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC5A5—kidney cancer	2.25e-06	6.74e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK1—kidney cancer	2.24e-06	6.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A5—kidney cancer	2.22e-06	6.68e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSMD7—kidney cancer	2.21e-06	6.64e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A1—kidney cancer	2.17e-06	6.51e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A1—kidney cancer	2.15e-06	6.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.15e-06	6.45e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—kidney cancer	2.11e-06	6.34e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—kidney cancer	2.1e-06	6.31e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BCHE—kidney cancer	2.1e-06	6.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.09e-06	6.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—kidney cancer	2.07e-06	6.22e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.07e-06	6.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—kidney cancer	2.06e-06	6.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.05e-06	6.15e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—kidney cancer	2.04e-06	6.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.03e-06	6.1e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A1—kidney cancer	2e-06	6.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.98e-06	5.93e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA9—kidney cancer	1.96e-06	5.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—kidney cancer	1.95e-06	5.84e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.94e-06	5.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.93e-06	5.8e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.91e-06	5.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—kidney cancer	1.9e-06	5.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TSC2—kidney cancer	1.9e-06	5.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—kidney cancer	1.89e-06	5.67e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.88e-06	5.64e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—kidney cancer	1.88e-06	5.63e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POMC—kidney cancer	1.86e-06	5.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.83e-06	5.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—kidney cancer	1.81e-06	5.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—kidney cancer	1.79e-06	5.38e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—kidney cancer	1.79e-06	5.38e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—kidney cancer	1.71e-06	5.14e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POMC—kidney cancer	1.71e-06	5.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—kidney cancer	1.7e-06	5.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.68e-06	5.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—kidney cancer	1.68e-06	5.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—kidney cancer	1.68e-06	5.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—kidney cancer	1.67e-06	5.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CRABP1—kidney cancer	1.67e-06	5e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—kidney cancer	1.66e-06	4.99e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—kidney cancer	1.65e-06	4.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.62e-06	4.87e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—kidney cancer	1.58e-06	4.74e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—kidney cancer	1.58e-06	4.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—kidney cancer	1.58e-06	4.73e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.56e-06	4.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ITPR2—kidney cancer	1.55e-06	4.65e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—kidney cancer	1.54e-06	4.61e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—kidney cancer	1.48e-06	4.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.47e-06	4.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.46e-06	4.37e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—kidney cancer	1.44e-06	4.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—kidney cancer	1.41e-06	4.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ACHE—kidney cancer	1.41e-06	4.24e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—kidney cancer	1.36e-06	4.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SCARB1—kidney cancer	1.34e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POMC—kidney cancer	1.34e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS1—kidney cancer	1.32e-06	3.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—kidney cancer	1.32e-06	3.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—kidney cancer	1.3e-06	3.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSMD7—kidney cancer	1.3e-06	3.89e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—kidney cancer	1.29e-06	3.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—kidney cancer	1.28e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—kidney cancer	1.28e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—kidney cancer	1.27e-06	3.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—kidney cancer	1.23e-06	3.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—kidney cancer	1.22e-06	3.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—kidney cancer	1.21e-06	3.62e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—kidney cancer	1.19e-06	3.56e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POMC—kidney cancer	1.18e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A1—kidney cancer	1.17e-06	3.52e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POMC—kidney cancer	1.16e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—kidney cancer	1.14e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.12e-06	3.36e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—kidney cancer	1.11e-06	3.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POMC—kidney cancer	1.08e-06	3.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—kidney cancer	1.07e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—kidney cancer	9.79e-07	2.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—kidney cancer	9.49e-07	2.85e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—kidney cancer	9.38e-07	2.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—kidney cancer	9.3e-07	2.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—kidney cancer	9.28e-07	2.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—kidney cancer	9.23e-07	2.77e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—kidney cancer	9.11e-07	2.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK1—kidney cancer	9.03e-07	2.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—kidney cancer	9e-07	2.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—kidney cancer	8.65e-07	2.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—kidney cancer	8.53e-07	2.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—kidney cancer	8.53e-07	2.56e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—kidney cancer	8.37e-07	2.51e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—kidney cancer	8.18e-07	2.45e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—kidney cancer	8.1e-07	2.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—kidney cancer	7.83e-07	2.35e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—kidney cancer	7.55e-07	2.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—kidney cancer	6.56e-07	1.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POMC—kidney cancer	6.36e-07	1.91e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—kidney cancer	5.77e-07	1.73e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—kidney cancer	5.71e-07	1.71e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—kidney cancer	5.32e-07	1.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—kidney cancer	5.07e-07	1.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—kidney cancer	4.42e-07	1.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—kidney cancer	3.12e-07	9.36e-06	CbGpPWpGaD
